Form 8-K - Current report:
SEC Accession No. 0001213900-20-013839
Filing Date
2020-06-01
Accepted
2020-06-01 17:08:58
Documents
4
Period of Report
2020-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea121903-8k_aytubioscience.htm 8-K 33794
2 EARLY PAYMENT AGREEMENT, DATED MAY 29, 2020 ea121903ex10-1_aytubio.htm EX-10.1 27403
3 PRESS RELEASE, DATED JUNE 1, 2020 ea121903ex99-1_aytubio.htm EX-99.1 12241
4 PRESS RELEASE, DATED JUNE 1, 2020 ea121903ex99-2_aytubio.htm EX-99.2 18889
  Complete submission text file 0001213900-20-013839.txt   93695
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 20934248
SIC: 2834 Pharmaceutical Preparations